EcoDrugPlus

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSUPAG00010000883
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSUPAG00010020003
Gene Symbol: GSK3B
1 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSUPAG00010007911
Gene Symbol: GNRHR
1 Cross references
96 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSUPAG00010007648
Gene Symbol: GHRHR
3 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSUPAG00010019371
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSUPAG00010017764
Gene Symbol: GUCY1A1
3 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSUPAG00010007868
Gene Symbol: GUCY1A2
1 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSUPAG00010017741
Gene Symbol: GUCY1B1
1 Cross references
209 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSUPAG00010023010
Gene Symbol: HRH1
1 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSUPAG00010003459
Gene Symbol: HRH2
1 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSUPAG00010008523
Gene Symbol: HRH3
3 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSUPAG00010012682
Gene Symbol: HRH4
3 Cross references
105 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).